Research Article

Urinary Biomarker Panel to Improve Accuracy in Predicting Prostate Biopsy Result in Chinese Men with PSA 4–10 ng/mL

Table 5

Net benefit and reduction in avoidable biopsies in predicting high-grade prostate cancer for the base model and improved model compared to the ‘‘treat-all’’ strategy to biopsy every patient for different threshold probabilities in the same range.

Threshold probability (%)152025303540

Net benefitBase model17.311.19.07.57.14.9
Improved model19.217.414.812.210.210.9
Treat all14.28.82.7−4.2−12.2−21.6

Net reduction in the number of biopsiesBase model17.89.018.927.335.939.8
Improved model28.734.436.138.341.648.8